Skip to search formSkip to main contentSkip to account menu

Anti-Idiotype Vaccine

A vaccine made of antibodies that see other antibodies as the antigen and bind to it. Anti-idiotype vaccines can stimulate the body to produce… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Cytolytic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer
Aberrant accumulation of a specific sialic acid has been shown to exist in many human malignant cell membranes termed as N… 
2015
2015
Peptide-based self-assembled nanovaccine system targeting Group A Streptococcus infection
H septicaemia (HS) is a fatal systemic disease of livestock most commonly affected are buffalo, cattle, pigs and camels… 
2013
2013
Immunopotentiation of outer membrane protein through anti-idiotype Pasteurella multocida vaccine in rabbits.
Review
2009
Review
2009
Dendritic cell vaccination in melanoma patients: Update and subgroup analysis of clinical response to post-vaccine treatment.
9042 Background: Dendritic cells (DCs) play a crucial role in the interplay between innate and adaptive immune response towards… 
Review
2004
Review
2004
Anti-idiotypic antibodies as vaccines against carbohydrate antigens
ConclusionsIn 1981 Nisonoff and Lamoyi [24] and Roitt and co-workers [28] suggested that internal image or anti-idiotypic… 
Highly Cited
1997
Highly Cited
1997
Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
We have generated an immunoglobulin G1 (IgG1) murine monoclonal anti-idiotype antibody (Ab2) designated ACA125, which mimics a… 
1995
1995
Immunization with anti-idiotype vaccine SCV 106 prolongs survival time of cancer patients with metastatic colorectal cancer: A randomized double blind clinical trial
1993
1993
Active Specific Immunotherapy of Hodgkin's Lymphoma by an Anti‐idiotype Vaccine against the Hodgkin‐Associated CD30 Antigen
1987
1987
Protective anti-idiotype vaccine against Schistosoma mansoni infection.
Vaccine development may be the most cost-effective way to ultimately control schistosomiasis, a disease that affects 200 million… 
1987
1987
Protective anti-idiotype vaccine against Schistosoma mansoni infection.
Vaccine development may be the most cost-effective way to ultimately control schistosomiasis, a disease that affects 200 million… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)